Neurological Biomarkers Market, By Type (Imaging, Proteomic, Genomic, Metabolomic, Others), By Application (Multiple Sclerosis, Alzheimers Disease, Autism Spectrum Disorder, Parkinsons Disease, Others), By End-use (Research Organizations, Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, Others), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Neurological biomarkers market size was valued at USD 5,607.9 Million in 2022, expanding at a CAGR of 15.8% from 2023 to 2030.
Neurological biomarkers are the biomarkers used for calculating and evaluating a symptom or method for obtaining a pharmacological response to a particular treatment. Additionally, they are extensively used for the identification of various diseases, such as autism, Parkinson\'s disease, and depression. Moreover, the general types of neurological biomarkers are metabolomics imaging, genomics, and proteomics.
Neurological Biomarkers Market- Market Dynamics
- Increasing Technological Advancements and Increasing Development of Precision Medicine
Increasing advancements in biomarkers, including biomarker signatures, make neurological diseases more treatable. As a result, in faster drug development, early diagnosis, and noninvasive testing. In addition, digital biomarkers provide various pharmaceutical companies as well as supplemental information to conclude the decisions for clinical trials. This, in turn, such factors fuel the market growth of neurological biomarkers. Moreover, in personalized medicine, biomarker research in neurodegenerative disease is a large advancing area. Various molecules have been associated and assessed with varied neurodegenerative disorders. Thus, the biopharmaceutical industry is impacted by the evolution of precision medicine. From biopharma to diagnostics companies’ different players with several functions, including commercial operations to research and development will observe a huge change. This is attributed to positively impacting the market growth. However, protracted biomarker development cycles and high startup costs are expected to restrain market growth. Furthermore, the wide presence of organizations offering funds at numerous stages of research is expected to provide a great opportunity for market expansion. To support research associated with health disparities in Alzheimer\'s and brain aging, the National Institutes of Health (NIH) is providing additional funds, therefore this factor may fuel the market growth.
Neurological Biomarkers Market- Key Insights
- As per the analysis shared by our research analyst, the global neurological biomarkers market is estimated to grow annually at a CAGR of around 15.8% over the forecast period (2023-2030)
- The neurological biomarkers industry is projected to grow at a significant rate due to the increasing advancements in biomarkers
- Based on type segmentation, genomic was predicted to show maximum market share in the year 2022
- Based on application segmentation, Alzheimer\'s disease was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Neurological Biomarkers Market- Segmentation Analysis:
The global neurological biomarkers market is segmented on the basis of type, application, end-use, and region.
The market is divided into four categories based on type: imaging, proteomic, genomic, metabolomic, and others. The genomic segment is likely to maintain its dominance during the forecast period. The segment provides various opportunities for the development of personalized medicines and diagnostics based on an individual’s predisposition to the disease & specific genetic variations. Additionally, methods used for the identification of the presence or studying genomic biomarkers for detecting disease-associated DNA sequence variants include whole-genome association studies using Single Nucleotide Polymorphisms (SNPs), array Comparative Genomic Hybridization (CGH), whole-genome resequencing, and gene expression profiling.
The market is divided into four categories based on application: multiple sclerosis, Alzheimer\'s disease, autism spectrum disorder, Parkinson\'s disease, and others. The Alzheimer\'s disease segment is expected to dominate the market. The growth is attributed to the increasing disease burden and product availability for clinical use, including imaging biomarkers-amyloid PET tracers for diagnosis. Moreover, non-profit and government organizations are offering a plethora of research opportunities that may boost market growth.
The market is divided into three categories based on end-use: research organizations, hospital & hospital laboratories, independent clinical diagnostic centers, and others. The hospital & hospital laboratories segment is likely to maintain its dominance over the forecast period due to a rise in hospitalization. Additionally, hospital facilities are enhanced by the ongoing development of healthcare infrastructure. Many blood-based biomarker assays are owned by hospitals and utilized in significant volumes. Moreover, research organizations are accounted to the grow at the fastest owing to the rising adoption of biomarkers ambulatory Surgery Centers (ASCs) and pharmaceutical companies for drug discovery & development
Neurological Biomarkers Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Neurological Biomarkers Market- Competitive Landscape:
The rise in the prevalence of neurological diseases like dementia, brain tumors, migraines, epilepsy, and Alzheimer’s disease is attributed to the growth of the market. Additionally, in neurological disorders, the factors such as the requirement for early diagnosis and technological advancements are contributing to market growth. Moreover, strategies adopted by market players that allow them to utilize led to the development of innovative products and enhance their supply chain. Based on this, the strategies include the launch of various products, collaboration, agreement, acquisition, and technological advancements to gain a foothold in the market. For instance, in August 2020, Enigma Biomedical Group announced signing an agreement to License Novel Neuro Imaging Biomarkers from Janssen. Additionally, these biomarkers hold great promise to offer essential new tools in the advancement of our understanding of a range of neurodegenerative diseases, including Alzheimer ’s disease and other dementias.
Recent Developments:
- For instance, in April 2021, Quanterix Corp. introduced a webinar with top industry professionals to discuss neurological advancements related to the ultra-sensitive measurement of pTau181, pTau217, pTau231, and other neurological biomarkers.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NEUROLOGICAL BIOMARKERS MARKET KEY PLAYERS
- PERKINELMER INC.
- Abbott Laboratories
- Quanterix
- Thermo Fisher Scientific, Inc.
- Neurobio
- Banyan Biomarkers, Inc.
- Bio-Rad Laboratories, Inc.
- HOFFMANN-LA ROCHE LTD.
- Merck & Co., Inc.
- DiaGenic ASA
- Johnson & Johnson Services, Inc.
- Myriad Genetics, Inc.
GLOBALNEUROLOGICAL BIOMARKERS MARKET, BY TYPE
- Imaging
- Proteomic
- Genomic
- Metabolomic
- Others
GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY APPLICATION
- Multiple Sclerosis
- Alzheimer’s Disease
- Autism Spectrum Disorder
- Parkinson’s Disease
- Others
GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY END-USE
- Research Organizations
- Hospital & Hospital Laboratories
- Independent Clinical Diagnostic Centers
- Others
GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Neurological Biomarkers Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Neurological Biomarkers Market Snippet by Type
2.1.2. Neurological Biomarkers Market Snippet by Application
2.1.3. Neurological Biomarkers Market Snippet by End-use
2.1.4. Neurological Biomarkers Market Snippet by Country
2.1.5. Neurological Biomarkers Market Snippet by Region
2.2. Competitive Insights
3. Neurological Biomarkers Key Market Trends
3.1. Neurological Biomarkers Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Neurological Biomarkers Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Neurological Biomarkers Market Opportunities
3.4. Neurological Biomarkers Market Future Trends
4. Neurological Biomarkers Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Neurological Biomarkers Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Neurological Biomarkers Market Landscape
6.1. Neurological Biomarkers Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Neurological Biomarkers Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
7.1.2. Imaging
7.1.3. Proteomic
7.1.4. Genomic
7.1.5. Metabolomic
7.1.6. Others
8. Neurological Biomarkers Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
8.1.2. Multiple Sclerosis
8.1.3. Alzheimer’s Disease
8.1.4. Autism Spectrum Disorder
8.1.5. Parkinson’s Disease
8.1.6. Others
9. Neurological Biomarkers Market – By End-use
9.1. Overview
9.1.1. Segment Share Analysis, By End-use, 2022&2030 (%)
9.1.2. Research Organizations
9.1.3. Hospital & Hospital Laboratories
9.1.4. Independent Clinical Diagnostic Centers
9.1.5. Others
10. Neurological Biomarkers Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Neurological Biomarkers Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Neurological Biomarkers Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Neurological Biomarkers Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Neurological Biomarkers Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Neurological Biomarkers Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Neurological Biomarkers Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. PERKINELMER INC.
11.2.2. Abbott Laboratories
11.2.3. Quanterix
11.2.4. Thermo Fisher Scientific, Inc.
11.2.5. Neurobio
11.2.6. Banyan Biomarkers, Inc.
11.2.7. Bio-Rad Laboratories, Inc.
11.2.8. F. HOFFMANN-LA ROCHE LTD.
11.2.9. Merck & Co., Inc.
11.2.10. DiaGenic ASA
11.2.11. Johnson & Johnson Services, Inc.
11.2.12. Myriad Genetics, Inc.
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
